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Although mast cells are best known for their role in mediating
allergic diseases, recent studies have highlighted the important role
that these cells play in the protection against infection with a
variety of organisms.
What Are Mast Cells?
Mast cells are leukocytes that are derived from haematopoietic
progenitor cells. They circulate in the blood in an immature form
before migrating to vascularised tissues, where they undergo final
differentiation and maturation with the help of stem-cell factor
and other cytokines secreted by endothelial cells and fibroblasts.
Mast cells are found in most tissues of the body, particularly in
locations that are in close contact with the external environment,
such as skin, airways, and intestines. They are, therefore, ideally
placed to participate in the early recognition of pathogens.
Activation of mast cells results in the release of a variety of soluble
factors. Within seconds of stimulation, mast cells can undergo
degranulation, rapidly releasing pre-formed mediators present
within cytoplasmic granules, including histamine, the proteases
tryptase and chymase, and pre-formed tumour necrosis factor-
alpha (TNF-a; reviewed in [1,2]). Shortly after the initiation of
degranulation, mast cells can produce lipid-derived eicosanoids
such as prostaglandin D2 and leukotriene C4 (LTC4). Finally, over
the course of hours, the transcriptional up-regulation of cytokines
and chemokines, including TNF-a and interleukin-4, can be
observed. Importantly, each of these responses may occur alone or
in combination depending on the stimulus. Because of their
location, their plasticity, and the various mediators they produce,
mast cells are important immune effector and modulatory cells
that help link innate and adaptive immunity in the fight against
pathogens.
How Do Pathogens Activate Mast Cells?
The best studied mechanism for the activation of mast cells is
via stimulation of the high-affinity immunoglobulin E (IgE)
receptor FceRI (reviewed in [3]). Binding of an antigen by
FceRI-bound specific IgE leads to FceRI clustering, which in turn
induces downstream signalling events and ultimately the release of
mediators. Although initially described in the context of allergy,
this response is important in the response to parasites, including
nematodes and malaria. Mast cells also express Fc receptors that
bind IgG and a variety of complement receptors, and therefore
can potentially respond to opsonised organisms. The role of these
receptors in mast cell activation during infection remains less well
defined.
As with other leukocytes, mast cells can also be activated by
directly interacting with pathogens through pattern recognition
receptors (PRRs), including the Toll-like receptors (TLRs), Nod-
like receptors, C-type lectins such as Dectin-1, and the
glycosylphosphatidylinositol-anchored protein CD48. Selective
engagement of PRRs is also an important mechanism in governing
the type of mast cell response. For example, while peptidoglycan
stimulation of bone marrow-derived mast cells via TLR2 leads to
both cytokine release and degranulation, lipopolysaccharide (LPS)
stimulation through TLR4 results in cytokine release alone [4].
Furthermore, Dectin-1 binding of fungal b-glucan induces the
release of LTC4 by mast cells [5] while CD48 binds to the
Escherichia coli adhesin FimH, and induces the release of TNF-a
[6].
How Do Mast Cells Contribute to Host Defence?
Mast cells are well placed to serve as immune sentinel cells to
both respond directly to pathogens and send signals to other tissues
to modulate both innate and adaptive immune responses
(Figure 1).
Mast cells can participate in direct killing of organisms by
phagocytosis and reactive oxygen species production [7], and can
produce antimicrobial peptides, such as cathelicidins, both
constitutively and in response to LPS or lipoteichoic acid exposure
[8]. These peptides were found to mediate killing of Group A
streptococci (GAS) in vitro and in vivo [8]. Additionally, similar to
neutrophils, mast cells have been found to produce extracellular
traps that encompass and kill organisms, such as GAS, in vitro [9].
Although these microbicidal responses may be important in some
infections, the relatively small number of mast cells in tissues
suggests that indirect effects of mast cells in coordinating host
innate and adaptive responses may be more important in the
balance of host defence. Future studies defining the relative
contributions of direct and indirect antimicrobial effects are
required.
Mast cells can modulate host innate immune responses through
the release of granular and secreted mediators (reviewed in [1,2]).
The release of histamine and other vasoactive mediators increases
vascular permeability and local blood flow, and can act on
smooth muscle to increase the expulsion of mucosal parasites. In
addition, histamine enhances epithelial cell mucus production,
which may aid in pathogen immobilisation and cytoprote-
ction. Finally, mast cell production of chemotactic factors can
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eosinophils (eotaxin), natural killer (NK) cells (IL-8), and
neutrophils (IL-8 and TNF-a).
Mast cell products have also been implicated in the regulation of
adaptive immune responses (reviewed in [1,2]). Mast cell–derived
cytokines and chemokines can enhance the migration of dendritic
cells (DCs; TNF-a and CCL20) and effector T cells (CXCL10/
IP10 and CCL5/RANTES) to the site of infection and to draining
lymph nodes. Mast cells can also function directly as antigen-
presenting cells, particularly for CD8
+ T cells. In addition, mast
cell products can enhance the maturation of immature DCs, and
up-regulate antigen presentation and the expression of co-
stimulatory molecules. Interestingly, while mast cell–derived
histamine was observed to favour the polarization of naive T cells
towards a Th2 phenotype by reducing DC production of IL-12
and increasing IL-10 secretion in response to LPS [10], direct
contact with mast cells can prime DCs to promote Th17 and Th1
polarization in vitro [11]. Although these findings require
confirmation in vivo, they suggest that mast cells may act to
promote the development of different immune responses depend-
ing on environmental and other cues.
Importantly, while mast cell responses may act to increase host
defence locally at the site of infection, it is also possible that mast
cell–mediated enhancement of inflammation could induce damage
of host tissues and worsen outcome during some infections. In
support of this hypothesis, a recent study observed that while
intraperitoneal mast cells were found to be protective in a model of
experimental polymicrobial intra-abdominal sepsis, extraperitone-
al mast cells in the same system produced pro-inflammatory IL-6,
which was associated with increased mortality [12]. This increase
in mortality was associated with increased circulating histamine,
suggesting that severe sepsis led to the induction of systemic mast
cell degranulation distal to the site of infection, and subsequent
overproduction of pro-inflammatory mediators.
Figure 1. Mast cells play a pivotal role in the host defence against pathogens. Pathogen recognition by host receptors leads to mast cell
activation and both direct and indirect antimicrobial responses. Abbreviations: AMP, antimicrobial peptide; CCL20, chemokine (C-C motif) ligand 20;
CR, complement receptor; DC, dendritic cell; FcR, Fc receptor; GPI, glycosylphosphatidylinositol; Ig, immunoglobulin; IL-8, interleukin-8; IP10,
interferon gamma-induced protein 10; LTC4, leukotriene C4; NK cell, natural killer cell; NOD, nucleotide oligomerisation domain like receptor; ROS,
reactive oxygen species; TLR, toll-like receptor; TNF-a, tumour necrosis factor-alpha.
doi:10.1371/journal.ppat.1002619.g001
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against Which Pathogens?
Recent studies have demonstrated that mast cells play a
protective role against many pathogens. Significant advances have
been made using mast cell–deficient mice, although the specific
mechanisms by which mast cells inhibit most pathogens remain
relatively undefined.
The first evidence supporting the protective role of mast cells
against pathogens came from studies of parasitic infections
including helminths, nematodes, and protozoa (reviewed in
[1,2]). Experiments using mast cell–deficient mice have found
that mast cells accelerate hookworm expulsion from the gut in
association with the production of mast cell protease 2. Similar
studies in models of Trichinella spiralis and Strongyloides infection
have found that mast cells mediate gut expulsion of nematodes and
limit the parasite tissue burden. Moreover, mast cell–deficient
mice develop increased parasite burden and larger lesions during
infection with Leishmania major in association with a reduction in
inflammation and IL-12 production at the site of infection. Finally,
a critical role for mast cell–derived TNF in limiting parasitaemia
in a murine model of malaria has been demonstrated by
reconstituting mast cell–deficient mice with mast cells derived
from wild-type and TNF-deficient mice [13].
More recently, the contributions of mast cells to antibacterial
immunity have also been established, particularly with respect to
gram-negative bacteria (reviewed in [1,2]). Mast cells have been
found to attenuate experimental pulmonary infection with
Klebsiella pneumoniae [14] and Mycoplasma pneumoniae; Pseudomonas
aeruginosa and GAS skin infection; Haemophilus influenzae otitis
media; and E. coli peritoneal and urinary infections, as well as
polymicrobial intra-abdominal sepsis [15].
Evidence that mast cells mediate antiviral immunity is more
limited. Mast cell activation by synthetic viral dsRNA led to the
recruitment of CD8
+ T cells to the site of infection that was absent
in mast cell–deficient mice [16]. Dengue infected mast cell–
deficient mice had an increased viral burden within draining
lymph nodes due to the lack of recruitment of NK and NK T cells
to the site of infection [17]. Conversely, however, in HIV
infection, mast cells may serve as a viral reservoir during latent
infection [18].
The role of mast cells in the pathogenesis of fungal infection is
even less well understood. In vitro studies have found that mast
cells released LTC4 in response to zymosan, a Saccharomyces
cerevisiae cell wall preparation [5]. A single study examining the
interaction of live fungi and mast cells in vitro found that Aspergillus
fumigatus hyphae induced degranulation of mast cells via an IgE-
independent mechanism [19]. Extending these studies in vivo will
be critical for understanding the role of mast cells in fungal
infections, as there may be important differences between the role
of mast cells in the defence against fungi and other eukaryotic
pathogens such as parasites. For example, while the induction of a
mast cell–associated Th2 response is classically protective in
parasitic infection, a Th2 response is usually detrimental during
fungal infection [20].
Could Enhancing Mast Cell Function Protect
against Infection?
In allergic diseases, mast cells are seen as harmful triggers of
chronic inflammation, and mast cell stabilizing agents and
inhibitors are frequently used as treatment. However, emerging
data suggest that mast cells are crucial in protecting the host from
many infections. Although substantial effort has been directed
towards defining and reversing the effects of corticosteroids and
other immunosuppressive agents on neutrophil, macrophage, and
dendritic cell function, similar studies are lacking for mast cells.
Failure of mast cells to function as immune sentinels early in
infection may play an important role in mediating susceptibility to
infection in patients receiving corticosteroids or other mast cell–
suppressing agents. Future studies will be required to understand
the effects of these agents on specific aspects of mast cell function
and subsequent susceptibility to specific infections. New strategies
focused on enhancing the beneficial roles of mast cells may
facilitate the early response to pathogens when the microbial
burden is low.
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